Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
RESEARCH TOOLSreports
Holding RARE?
Track your performance easily
Ultragenyx Pharmaceutical (RARE) Ownership Overview
9.06% Insiders
31.84% Mutual Funds
14.62% Other Institutional Investors
44.48% Public Companies and Individual Investors
The ownership structure of Ultragenyx Pharmaceutical (RARE) stock is a mix of institutional, retail and individual investors. Approximately 46.46% of the company’s stock is owned by Institutional Investors, 9.06% is owned by Insiders and 44.48% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 03, 2024 | Corazon (corsee) D. Sanders Director | xxxxxxxxxxxxx | $23932 |
| Jun 10, 2024 | Corazon (corsee) D. Sanders Director | xxxxxxxxxxxxx | $71391 |
| May 03, 2024 | Eric Crombez Evp And Chief Medical Officer | xxxxxxxxxxxxx | $15456 |
| Apr 19, 2024 | Eric Crombez Evp And Chief Medical Officer | xxxxxxxxxxxxx | $6262 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $12793 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $813479 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $2055994 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $4622310 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,898,812 | Institution | 8.72% | 354,340,706 | |
| 6,803,477 | Institution | 7.51% | 305,203,978 | |
| 3,859,447 | Institution | 4.26% | 173,134,792 | |
| 2,827,898 | Insider | 3.12% | 126,859,504 | |
| 2,166,185 | Institution | 2.39% | 97,175,059 | |
| 2,124,721 | Institution | 2.35% | 95,314,984 | |
| 2,103,740 | Institution | 2.32% | 94,373,776 | |
| 1,466,547 | Institution | 1.62% | 65,789,298 | |
| 1,366,623 | Institution | 1.51% | 61,306,708 | |
| 1,288,587 | Institution | 1.42% | 57,806,013 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,803,477 | Institution | 7.51% | 305,203,978 | |
| 2,124,721 | Institution | 2.35% | 95,314,984 | |
| 2,103,740 | Institution | 2.32% | 94,373,776 | |
| 1,288,587 | Institution | 1.42% | 57,806,013 | |
| 1,247,430 | Institution | 1.38% | 55,959,710 | |
| 1,245,879 | Institution | 1.38% | 55,890,132 | |
| 1,145,534 | Institution | 1.26% | 51,388,655 | |
| 1,050,818 | Institution | 1.16% | 47,139,695 | |
| 833,582 | Institution | 0.92% | 37,394,489 | |
| 790,346 | Institution | 0.87% | 35,454,922 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,717,959 | Institution | 3.00% | 111,708,115 | |
| 2,162,806 | Institution | 2.39% | 88,891,327 | |
| 1,309,815 | Institution | 1.45% | 59,020,264 | |
| 1,374,396 | Institution | 1.52% | 56,487,676 | |
| 1,213,202 | Institution | 1.34% | 49,862,602 | |
| 575,555 | Institution | 0.64% | 25,819,397 | |
| 468,033 | Institution | 0.52% | 20,995,960 | |
| 429,540 | Institution | 0.47% | 19,355,072 | |
| 312,696 | Institution | 0.35% | 14,027,543 | |
| 272,206 | Institution | 0.30% | 12,211,161 |
FAQ
Who Owns Ultragenyx Pharmaceutical (RARE)?
According to the latest TipRanks data, approximately 14.62% of the company's stock is held by institutional investors, 9.06% is held by insiders, and 44.48% is held by retail investors.
What percentage of Ultragenyx Pharmaceutical (RARE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 14.62% of Ultragenyx Pharmaceutical (RARE) stock is held by institutional investors.
What percentage of Ultragenyx Pharmaceutical (RARE) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.48% of Ultragenyx Pharmaceutical (RARE) stock is held by retail investors.
Who owns the most shares of Ultragenyx Pharmaceutical (RARE)?
Vanguard owns the most shares of Ultragenyx Pharmaceutical (RARE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.